120 results
Page 2 of 6
8-K
EX-10.2
khkfdk3k ky4
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
zyrp6 vkowgxxxufx6u
13 Sep 22
InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market
9:59pm
8-K
EX-10.1
q99xroh iqorj2rpex
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
424B3
m5fv5gmcwfh5ldbap
6 Jul 22
Prospectus supplement
2:43pm
D
a51b 73plf
8 Jun 22
$5M in equity / options, sold $5M, 1 investor
2:26pm
8-K
EX-10.1
tg8rb91pwhia
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.3
d6g57315duodi3b
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
8-K
EX-10.2
i245tyji
3 Jun 22
Entry into a Material Definitive Agreement
9:51pm
424B5
xxt1jvhfa9f3d7e
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
xalitg3 445s0
25 Apr 22
Prospectus supplement
5:02pm
8-K
EX-10.1
yo6cietq
7 Apr 22
Entry into a Material Definitive Agreement
4:47pm
424B3
sm1q467 k5oihnjn0r
7 Apr 22
Prospectus supplement
4:46pm
S-3
uhjfizi7j
4 Feb 22
Shelf registration
4:36pm
8-K/A
EX-99.2
7a52bkh337cryao
22 Dec 21
Audited Financial Statements
12:00am